This paper is in the following e-collection/theme issue:

Cost-Effectiveness and Economics (285) Cardiac Arrhythmia, Atrial Fibrillation (103) Mobile Apps for Cardiology (159) mHealth in a Clinical Setting (665) Mobile Health (mhealth) (3125) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1546) Economic Evaluations of mHealth Programs and Infrastructures (39) E-Health / Health Services Research and New Models of Care (597)

Published on in Vol 24, No 4 (2022): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29408, first published .
Cost-Effectiveness of Mobile Health–Based Integrated Care for Atrial Fibrillation: Model Development and Data Analysis

Cost-Effectiveness of Mobile Health–Based Integrated Care for Atrial Fibrillation: Model Development and Data Analysis

Cost-Effectiveness of Mobile Health–Based Integrated Care for Atrial Fibrillation: Model Development and Data Analysis

Authors of this article:

Xueyan Luo1, 2, 3 Author Orcid Image ;   Wei Xu4 Author Orcid Image ;   Wai-Kit Ming5 Author Orcid Image ;   Xinchan Jiang6 Author Orcid Image ;   Quan Yuan7 Author Orcid Image ;   Han Lai1 Author Orcid Image ;   Chunji Huang8 Author Orcid Image ;   Xiaoni Zhong1, 3 Author Orcid Image
Article Authors Cited by (10) Tweetations (3) Metrics

Xueyan Luo   1, 2, 3 , MSc ;   Wei Xu   4 , PhD ;   Wai-Kit Ming   5 , MD, PhD ;   Xinchan Jiang   6 , PhD ;   Quan Yuan   7 , PhD ;   Han Lai   1 , MSc ;   Chunji Huang   8 , PhD ;   Xiaoni Zhong   1, 3 , MSc

1 School of Public Health and Management, Chongqing Medical University, Chongqing, China

2 School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, China

3 Research Center for Medicine and Social Development, Chongqing Medical University, Chongqing, China

4 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjin, China

5 Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong, China (Hong Kong)

6 School of Pharmacy, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)

7 Chong Qing Pharmaceutical Group Co Ltd, Chongqing, China

8 School of Basic Medical Science, Army Medical University, Chongqing, China

Corresponding Author:

  • Xiaoni Zhong, MSc
  • School of Public Health and Management
  • Chongqing Medical University
  • 1 Yi Xue Lu
  • Yu Zhong District
  • Chongqing, 400016
  • China
  • Phone: 86 (023)68485008
  • Email: zhongxiaoni@cqmu.edu.cn